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reported characteristics associated with AAA in men and
women, and in that study there were no formal compar-
isons between the sexes.11 A better understanding of sex-
ual differences in AAA epidemiology should improve
diagnostic vigilance and provide insights into pathophysi-
ology. The purpose of this article is to compare associa-
tions with AAA in men and women who underwent
ultrasound screening as part of the Department of
Veterans Affairs (VA) Aneurysm Detection and Manage-
ment (ADAM) study. The overall results of this screening
program have been previously published.2,3
METHODS
The ADAM study was a randomized clinical trial that
compared immediate surgery with imaging surveillance in
patients aged 50 to 79 years with asymptomatic AAA 4.0 to
5.4 cm in diameter.15 Ultrasound screening clinics were
established at the participating VA medical centers to sup-
port recruitment into the trial. The study was approved by
the human rights committee at the VA Cooperative Studies
Program coordinating center and by the institutional review
boards at the participating centers.
Details of the ADAM screening program have been
previously described2,3 and are reviewed here. Active
patients (those treated in the current or previous fiscal year
or having future appointments) aged 50 to 79 years at the
16 participating VA medical centers were invited by letter
to attend a screening clinic from 1992 to 1997. Inadver-
tent repeat screenings were identified with social security
numbers, and the later screening was excluded. Subjects
with a prior diagnosis of AAA were also excluded.
Before undergoing the ultrasound examination, all
subjects completed a brief questionnaire addressing demo-
Abdominal aortic aneurysm (AAA) is several times
more common in men than in women, even after adjust-
ing for other known risk factors.1-3 As a result, most stud-
ies of AAA have focused primarily on men. Why AAA is
less common in women remains unknown, but evidence of
other differences in AAA epidemiology between men and
women is emerging. In patients evaluated for the UK
Small Aneurysm Trial, the rate of AAA rupture was three
times higher in women than in men after adjustment for
age, body size, and initial AAA diameter.4 In several large
population-based series investigators have reported the
postoperative mortality rate after AAA repair to be 30% to
50% higher in women than in men,5-8 though smaller
studies have reported no difference.9,10 There has also
been recent evidence that AAA is more closely associated
with stroke in women11,12 and that women with AAA may
have a higher frequency of suprarenal aortic involve-
ment,13,14 but these findings require confirmation. We are
aware of only one previous study in which investigators
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Objective: The purpose of this study was to compare abdominal aortic aneurysm (AAA) associations in men and women.
Methods: Veterans aged 50 to 79 years without a previous history of AAA underwent ultrasound screening for AAA
after completing a questionnaire on demographic information and potential risk factors.
Results: A total of 122,272 men and 3450 women were successfully screened. An AAA of 3.0 cm or greater in diame-
ter was found in 4.3% of men and 1.0% of women (P < .001). Contrary to a previous report, we did not find suprarenal
aortic enlargement accompanying AAA to be more common in women. The principal associations that we have previ-
ously reported for AAA in this cohort (age, smoking, family history of AAA, and a negative association with diabetes)
were all similar in women compared with men. In age- and smoking-adjusted models, the interaction terms indicated
that black race and cancer were more strongly associated with AAA in women than men (P < .05). Height and cerebral
vascular disease were also more strongly associated with AAA in women than in men, but these interaction terms did
not reach statistical significance (P < .10). Although the other differences were unexpected and require confirmation,
the trend toward a stronger association of cerebral vascular disease with AAA in women is consistent with two previ-
ous reports.
Conclusions: Despite the much lower prevalence of AAA in women, the most important associations with AAA are sim-
ilar to those seen in men. Our data provide some support for a previous finding that cerebrovascular disease may be
more closely associated with AAA in women than in men. (J Vasc Surg 2001;34:122-6.)
graphic information and possible risk factors for AAA
(Appendix, online only). Subjects were asked if they had
ever been told by a doctor that they had the condition in
question (eg, high blood pressure). The questionnaire was
developed for the study, piloted at the participating cen-
ters, and revised accordingly before the study began.
Reliability was assessed in 360 screened subjects with AAA
by comparison with data collected by a study nurse after a
discussion with the subject and review of the subject’s
medical records. There was a reasonably high level of
agreement on most topics, but agreement on high choles-
terol and claudication was only fair.2
The abdominal aorta was measured above and below
the renal arteries with a 3.5-MHz real-time sector scanner.
The ultrasonographers were instructed to scan the aorta in
both the anteroposterior and lateral planes and to report
the maximum external diameter in any direction at the
widest point of any dilatation for both the suprarenal and
infrarenal segments. An aortic diameter of 3.0 cm was
used to define AAA, on the basis of our previous observa-
tions that the associations were similar for cutoff points of
3.0 cm or 4.0 cm,2,3 and that the adjusted mean infrarenal
aortic diameter in women without AAA was only 0.14 cm
less than in men without AAA in this cohort, suggesting
little advantage to varying the definition of AAA by sex.16
Analyses to determine the associations between the
items on the questionnaire and the presence of AAA were
performed with logistic regression, as previously de-
scribed.2,3 Composite variables were formed from multiple
questions used to identify coronary artery disease, hyperten-
sion, hypercholesterolemia, and, in a separate analysis, any
atherosclerosis. “Don’t know” responses were treated as
“no” responses for specific diseases, on the assumption that
if an individual had a disease, he or she would be aware of it.
This assumption was not made for hypercholesterolemia and
hypertension, which are commonly asymptomatic, and
“don’t know” responses for these conditions were consid-
ered to be “missing” and were excluded.
The number of AAAs in women was not large enough
to generate valid multivariate models for AAAs in women
with all variables included in the questionnaire, so univari-
ate models are shown. Peduzzi et al17 have shown that in
logistic regression, a ratio of events per variable of 5 or less
produced unreliable results, whereas a ratio of 10 or more
resulted in no major problems. To assess differences
between the sexes in the association of variables with AAA,
we examined the interaction between each variable and
the sex variable in models that included both men and
women. Although the total number of events in this
model was large, we did not enter all variables into a sin-
gle model, again out of concern for the small number of
AAAs in women. We therefore created two-variable mod-
els to assess the interaction between sex and each of the
other variables and four-variable models to which age and
smoking were added. A significant interaction between a
variable and the sex variable served to indicate that the dif-
ference between the sexes (in the association of that vari-
able with AAA) was statistically significant.
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RESULTS
Of 126,195 subjects who were successfully screened,
473 did not answer the sex question, resulting in a study
group of 125,722, of whom 3450 were women.
Characteristics of the women and men screened are shown
in Table I.
Of the men, 5225 (4.3%) had an AAA 3.0 cm or
greater, of whom 1634 (1.3%) had an AAA 4.0 cm 
or greater. Thirty-four women (1.0%) had an AAA 3.0 cm
or greater, of whom four (0.1%) had an AAA 4.0 cm or
greater (4.0, 4.3, 4.8, and 5.9 cm). The difference
between the sexes was statistically significant for both cut-
off points (P < .001).
Two (5.9%) of the 34 women with infrarenal aortic
diameters of 3.0 cm or more also had suprarenal aortic
diameters of 3.0 cm or more, compared with 464 of 5032
men (9.2%, P = not significant; 193 men had missing
suprarenal values). Because infrarenal aortic diameters of 4.0
cm or more were rare in women and were associated with a
high (14.9%) rate of suprarenal enlargement in men, we also
examined the rate of suprarenal involvement by sex in only
those subjects with infrarenal aortic diameters of 3.0 to 3.9
cm. In this group, the proportions of women and men with
suprarenal aortic diameters of 3.0 cm or more were nearly
identical (6.7% and 6.9%, respectively).
Table II shows the results of the univariate logistic
regression models for AAA in women and men. The
strongest associations in men (age, smoking, and family his-
tory of AAA) were all similar in women, as was the negative
Table I. Characteristics by sex of veterans screened for
AAA
Characteristic Women Men
No. 3450 122,272
Age (y) 66.1 ± 8.0 65.9 ± 7.5
Race
White 90.4 86.5
Black 5.6 8.3
Other 4.1 5.2
Height (cm) 163.5 ± 7.2 176.9 ± 6.9
Weight (kg) 73.5 ± 16.2 85.5 ± 15.7
Waist circumference (cm) 85.4 ± 14.0 96.5 ± 11.0
Family history of AAA 9.2 4.9
Ever smoked regularly* 55.4 75.4
No. of years smoked 26.8 ± 14.6 29.5 ± 14.5
Current smoker 15.6 18.5
Hypertension 52.4 54.1
High cholesterol 64.9 51.9
Coronary artery disease 28.3 37.0
Claudication 3.7 6.0
Cerebral vascular disease 10.3 10.8
Deep venous thrombosis 10.8 6.9
Diabetes mellitus 13.2 17.8
Chronic obstructive 12.3 13.5
pulmonary disease
Nonskin cancer 14.5 12.2
Plus/minus values are means ± SD; all other values are percentages.
P < .05 for all comparisons between men and women except for age and
cerebral vascular disease.
*More than 100 cigarettes over lifetime.
association with diabetes (which did not reach statistical sig-
nificance in women). The association with AAA was signifi-
cantly stronger in women than men (ie, the interaction with
sex was significant) for cancer, and the interaction with sex
approached statistical significance for black race, height, and
cerebral vascular disease. When the model was adjusted for
age and smoking (the two strongest associations), the results
were similar: the interaction of sex with black race and can-
cer was significant (P < .05), height and cerebral vascular dis-
ease remained near significant (P values of .08 and .07,
respectively), and P values for all other interactions with sex
remained greater than .30.
DISCUSSION
In this study, women were less than one fourth as likely
as men to have an AAA 3.0 cm or greater and less than one
tenth as likely to have an AAA 4.0 cm or greater.
Characteristics of men and women screened were generally
similar. The greatest difference was in family history of
AAA, which was nearly twice as common in women, possi-
bly reflecting a greater awareness of family history on the
part of the women. Although a small proportion of the sub-
jects screened in our study were women, to our knowledge,
this represents the largest cohort of women for whom char-
acteristics associated with AAA have been reported.
Despite a large total number of patients screened in
this study, the low proportion of women screened com-
bined with the low prevalence of AAA in women resulted
in a small number of AAA in women. Nevertheless, most
of the important associations observed in men (age, smok-
ing, family history of AAA, and a negative association with
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diabetes) were also observed in women (though the neg-
ative association with diabetes did not reach statistical sig-
nificance in women). The association of these factors with
AAA has been discussed in previous publications.2,3
Our data also reveal a significant difference between
men and women in the association of AAA with cancer
and near-significant differences with black race, height,
and cerebral vascular disease. Because the differences
observed in race, cancer, and height were not anticipated
and are not readily explained, they are probably best con-
sidered as hypothesis generating and require confirmation
in future studies.
The situation with cerebral vascular disease (defined in
our questionnaire as “any kind of stroke, permanent or
brief”) is somewhat different. Recently, a Dutch study
found stroke to be significantly associated with AAA in
women but not in men,11 and a British study12 found the
association of stroke with AAA to be significantly stronger
in women than in men (odds ratios of 3.71 and 1.89,
respectively). The authors did not comment on this finding
in either of these studies, and we are aware of no other stud-
ies providing data pertinent to this issue. Testing this
hypothesis was a principal goal of the current analysis, and
the odds ratios we observed (3.20 for women and 1.55 for
men) were similar to the British results. The sex difference
we observed was not significant at the .05 level and so must
be interpreted with caution, but the consistency among
these three studies is supportive of this being a true differ-
ence. Why cerebrovascular disease might be more closely
associated with AAA in women than men is unclear, espe-
cially because there was no similar trend in the other athero-
Table II. Univariate models of associated factors for AAA ≥ 3.0 cm in diameter versus normal (defined as infrarenal
aortic diameter < 3.0 cm) by sex
Odds ratio (95% CIs)
Factors Women Men Significance of sex difference
No. of subjects with/without 34/3416 5225/117,047
AAA
Age (per 7 y*) 1.79 (1.22, 2.62) 1.54 (1.50, 1.59)
Black race (vs white) 1.58 (0.48, 5.23) 0.48 (0.41, 0.55) P = .05
Height (per 7 cm*) 1.51 (1.12, 2.03) 1.14 (1.11, 1.17) P = .07
Weight (per 16 kg*) 1.18 (0.87, 1.61) 1.04 (1.01, 1.07)
Waist circumference (per 11 cm*) 1.07 (0.82, 1.39) 1.14 (1.11, 1.17)
Family history of AAA 2.60 (1.12, 6.01) 1.96 (1.77, 2.16)
Ever smoked regularly† 3.80 (1.57, 9.20) 3.34 (3.04, 3.67)
Hypertension 1.15 (0.58, 2.28) 1.32 (1.25, 1.39)
High cholesterol 1.05 (0.54, 2.07) 1.30 (1.23, 1.38)
Coronary artery disease 1.38 (0.68, 2.81) 1.77 (1.67, 1.87)
Claudication 1.64 (0.39, 6.92) 1.51 (1.36, 1.66)
Cerebral vascular disease 3.20 (1.48, 6.92) 1.55 (1.43, 1.67) P = .07
Deep venous thrombosis 1.10 (0.39, 3.14) 1.12 (1.01, 1.24)
Diabetes mellitus 0.63 (0.19, 2.08) 0.70 (0.65, 0.76)
Chronic obstructive pulmonary disease 1.54 (0.63, 3.74) 1.40 (1.30, 1.51)
Nonskin cancer 2.48 (1.18, 5.22) 1.05 (0.97, 1.14) P < .05
P values are for the interaction of the variable with sex when all subjects are included in the model. All P values other than those shown were greater than
.30.
*Approximately one SD.
†More than 100 cigarettes over lifetime.
sclerotic disease categories of coronary artery disease and
claudication. A better understanding of these relationships
may provide insights into the etiology of AAA.
We were unable to confirm a previous report from the
Cornell group13 that suprarenal aortic dilatation was more
common in women than men. A limitation of our study in
this regard is that we used ultrasound, which is less precise
when used to measure the proximal abdominal aorta than
when used to measure the distal aorta.18,19 The Cornell
study was based on computed tomograms but included
only 45 patients with AAA, of whom 13 were women
(Michael F. Silane, oral communication, May 1999).
These authors have also considered male-to-female ratios
in surgical series of suprarenal AAA that are lower than the
usually observed male-to-female ratios of AAA prevalence
to be evidence in support of this observation.14 However,
these series contained fewer than 160 patients combined
and represent consecutive operations at the reporting
institutions rather than population prevalence, so further
studies will be needed to resolve this issue.
Our study shows that despite the much lower preva-
lence of AAA in women, the most important associations
with AAA are similar to those seen in men. However, our
data also provide support for a previous finding that cere-
brovascular disease may be more closely associated with
AAA in women than in men.
The ADAM Veterans Affairs Cooperative Study coau-
thors also include Fred N. Littooy, MD, Department of
Surgery, Veterans Affairs Medical Center, Hines, Ill;
William C. Krupski, MD, Department of Surgery, Veterans
Affairs Medical Center, Denver, Colo; Ian L. Gordon, MD,
Department of Surgery, Veterans Affairs Medical Center,
Long Beach, Calif; Edmund P. Chute, MD, Department of
Surgery, Veterans Affairs Medical Center, Minneapolis,
Minn; Michel S. Makaroun, MD, Department of Surgery,
Veterans Affairs Medical Center, Pittsburgh, Pa; Gary W.
Barone, MD, Department of Surgery, Veterans Affairs
Medical Center, Little Rock, Ark; Dennis Bandyk, MD,
Department of Surgery, Veterans Affairs Medical Center,
Tampa, Fla; Gregory L. Moneta, MD, Department of
Surgery, MD Veterans Affairs Medical Center, Portland,
Ore; Raymond G. Makhoul, MD, Department of Surgery,
Veterans Affairs Medical Center, Richmond, Va; Charles W.
Acher, MD, Department of Surgery, Veterans Affairs
Medical Center, Madison, Wis; Linda M. Graham, MD,
Department of Surgery, Veterans Affairs Medical Center,
Ann Arbor, Mich; Steven Sparks, MD, Department of
Surgery, Veterans Affairs Medical Center, San Diego, Calif;
Alex Furst, MD, Department of Surgery, Veterans Affairs
Medical Center, Miami, Fla; Joseph H. Rapp, MD,
Department of Surgery, Veterans Affairs Medical Center,
San Francisco, Calif; Robert Cambria, MD, Department of
Surgery, Veterans Affairs Medical Center, Milwaukee, Wis;
Steven Busuttil, MD, Department of Surgery, Veterans
Affairs Medical Center, Cleveland, Ohio; Louis M. Messina,
MD, Department of Surgery, UCSF, San Francisco, Calif;
David J. Ballard, MD, PhD, Baylor Health Care System,
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Medical Center, Minneapolis, Minn.
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Larson, VA Medical Center, Minneapolis, Minn; Donovan
B. Reinke, MD, and Howard J. Ansel, MD, Central
Computed Tomographic Scan Laboratory, VA Medical
Center, Minneapolis, Minn.
Investigators at VA Medical Centers include Gerald B.
Zelenock, MD, Charles Shanley, MD, Clare Sekerak, RN,
Mary Lingg, RN, and Latonya Trohallis (Ann Arbor,
Mich); Allen W. Averbook, MD, Steven J. Busuttil, MD,
Linda Graham, MD, Charles L. Mesh, MD, Krista Kaelin,
RN, Theresa O’Malley, RN, Evelynn Wingard, RN, MS,
John Lindesmith, RN, and Julie Francosky, RT
(Cleveland, Ohio); Alex Furst, MD, Marwan Tabbara,
MD, Anselmo A. Nunez, MD, Ghislaine Paperwalla, RN,
Kay Nunez, RN, Christine Estep, RN, and James Taylor,
RT (Miami, Fla); William C. Krupski, MD, Pamela
Strecker, RN, and Linda Schoening, CCVT (Denver,
Colo); Fred N. Littooy, MD, John Maggio, PhD, and
Wendy Cote, RVT (Hines, Ill); Gary W. Barone, MD,
Mohammed Moursi, MD, Bernard W. Thompson, MD,
Brenda Kackley, RN, Becky Chesser, BSN, CRT, Rob
Little, RT, and Terry Wood, BSRT (Little Rock, Ark); Ian
Gordon, MD, Cheryl Kohl, RN, Gary Scully, RT, Rebecca
Complin, RVT, and Manju Akkinepali (Long Beach,
Calif); Charles W. Acher, MD, Judy Archibald, RN,
Jennifer Fitzsimons, BS, and Traci Jo Havlik, RTR
(Madison, Wis); Edmund P. Chute, MD, William D.
Payne, MD, Michael L. Schwartz, MD, Catherine
Proebstle, RN, Ronald Hedblad, RT, and Michael
Richardson, RT (Minneapolis, Minn); Michel S.
Makaroun, MD, Satish Muluk, MD, Cynthia Slivka, RN,
Nina Carnegie, RN, Tricia DeBoo, RN, Janice Freidel,
DMS, RT, and Jean Fuhs, RT (Pittsburgh, Pa); Gregory
L. Moneta, MD, Richard A. Yeager, MD, James M.
Edwards, MD, Roland Jemerson, RN, Troy Williams,
RVT, and Robert McCartney, RVT (Portland, Ore);
Raymond G. Makhoul, MD, Ann Grimsdale, RN, Laura
Bartnicki, RN, and Linda Tyree Joyner, RT (Richmond,
Va); Louis M. Messina, MD, Joseph H. Rapp, MD,
Shelley Dwyer, RN, Donna Collins, RN, Steven Vann
Smith, CVT, CCPT, and Harry Daughenbaugh, RDCS
(San Francisco, Calif); Steven Sparks, MD, Robert J. Hye,
MD, Edward J. Plecha, MD, Yehuda G. Wolf, MD, Gerry
Cali, RN, Terri Scala, RN, and Roger Hull, RCVT (San
Diego, Calif); Dennis Bandyk, MD, Dolores Bou-Eid,
RN, and Maureen Jackson Maynard, RT (Tampa, Fla);
Robert A. Cambria, MD, Julie Freischlag, MD, Christa
Kallio, RN, Susan Framberg, RN, Sandra Towne, RN, and
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Durham, NC, and Christopher R. B. Meritt, MD, New
Orleans, La (Planning Committee); David J. Ballard, MD,
PhD, Decatur, Ga, and C. William Cole, MD, Ottawa,
Ontario (Executive Committee).
The Data Monitoring Board included G. Patrick
Clagett, MD (cochairman), University of Texas
Southwestern Medical Center, Dallas, Tex; John D.
Corson, MB, ChB (cochairman), University of Iowa, Iowa
City, Iowa; William C. Cushman, MD, VA Medical Center,
Memphis, Tenn; C. Seth Landefeld, MD, VA Medical
Center, San Francisco, Calif; Theodore G. Karrison, PhD,
University of Chicago, Chicago, Ill; John P. Matts, PhD,
University of Minnesota, Minneapolis, Minn.
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Coordinating Center, West Haven, Conn, included Gary
R. Johnson, MS (study biostatistician); Angela Hudson,
MPH, Velma Williams-Estes, BS, Richard Vinisko, BS,
Rae Bartozzi, Ray Kilstrom, MBA, and Kathy Riester, BA
(statistical assistants); Kathy Newvine, BS, and Robert
Goodwin, MS (computer programmers); Peter Peduzzi,
PhD (director); Dorothea Collins, ScD; Peggy Antonelli
(administrative officer); Mary Smith (forms design); Lillie
Franklin, Pattie Collins, Stella Marcinauskis, and Bonita
Hunter, BS (data entry). Cooperative Studies Program
Administration at VA Headquarters: John R. Feussner,
MD, MPH (chief); Ping C. Huang, PhD.
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